Successful FDA inspection at Haupt Pharma Amareg in Regensburg / Germany
Haupt Pharma, one of Europe's leading contract developers and manufacturers, has successfully passed an inspection by the US Food and Drug Administration (FDA) at its site in Regensburg / Germany without any FDA-483 observation being issued.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.